Alcon becomes a separately traded standalone company | Novartis
Bausch Has a Good Model in Novartis' Spinoff of Alcon, Analysts Say | Barron's
Eye Care News - Vision Executives International Eye Care Recruitment
Novartis announces widely expected Alcon spinoff, plus $5B share buyback, to strengthen focus on biopharma | Fierce Pharma
NOVARTIS AG SPIN-OFF OF ALCON INC. SHARES ON APRIL 9, 2019 CANADA INCOME TAX GUIDELINES
Novartis provides details on Alcon spin-off | Berks Regional News | wfmz.com
Novartis hands investors Alcon spin-off, $5 billion share buyback | Reuters
Proposed Spin-off of Alcon
Novartis to spin off Alcon and launch a $5 billion share buyback
Proposed Spin-off of Alcon
Proposed Spin-off of Alcon
g258160.jpg
Proposed Spin-off of Alcon
Alcon Reports Second Quarter 2021 Results | Business Wire
An Investment Review of Alcon Inc. Since Its Spin-off from Novartis
g542888.jpg
Proposed Spin-off of Alcon
Novartis continues to 'reimagine' itself, as Alcon spin-off completed - PharmaTimes
g11685.jpg
Proposed Spin-off of Alcon
Proposed Spin-off of Alcon
Alcon Stock Trades Strongly in NYSE Debut After Novartis Spinoff | Barron's
g968482.jpg
Corporate security spin-off - mess up cost basis — Quicken
g1043486.jpg
Why Novartis is spinning off Alcon and sticking to Sandoz - YouTube
